You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult myelodysplastic syndrome

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)

Active, not recruiting
  • Myelodysplastic Syndromes
  • cyclophosphamide, fludarabine, and antithymocyte globulin
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

MDS Trial run by the National Cancer Institute (NCI) (KPT-8602, Inqovi)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2023

Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute

Recruiting
  • Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2021

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Buffalo (biological, drug, radiation)

Completed
Has Results
  • Chronic Myeloproliferative Disorders
  • +7 more
  • anti-thymocyte globulin
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 19, 2021

Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Recruiting
  • Myelodysplastic Syndrome (MDS)
  • +3 more
  • Cord Blood Transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 22, 2021

Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Scottsdale, Cleveland,

Completed
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Scottsdale, Arizona
  • +3 more
Jan 12, 2023

Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

Not yet recruiting
  • Acute Myeloid Leukemia
  • High-Risk and Very High-Risk Myelodysplastic Syndromes
  • (no location specified)
Jul 25, 2023

MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)

Recruiting
  • Myelodysplastic Syndromes
  • +5 more
  • description of MDS pzatient cohort
  • Brest, France
    Chu Brest
Oct 27, 2022

Haplo-HSCT for Elderly Acute Leukemia/ Myelodysplastic Syndrome

Not yet recruiting
  • Acute Leukemia
  • Myelodysplastic Syndromes
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 5, 2023

    AML, Adult Trial in Australia, China, United States (APG 2575 ramp up arm)

    Recruiting
    • AML, Adult
    • APG 2575 ramp up arm
    • Baltimore, Maryland
    • +6 more
    Aug 12, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Boston (BXCL701)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome With Excess Blasts-2
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 26, 2023

    Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Cytokine Induced Memory-like Natural Killer Cells
    • Interleukin-2
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2023

    Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome Trial in Columbus (Azacitidine, Quality-of-Life

    Recruiting
    • Secondary Myelodysplastic Syndrome
    • Therapy-Related Myelodysplastic Syndrome
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 1, 2022

    Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid

    Recruiting
    • Previously Treated Myelodysplastic Syndrome
    • +3 more
    • Fludarabine Phosphate
    • +9 more
    • Chicago, Illinois
      University of Chicago Comprehensive Cancer Center
    Jan 7, 2022

    MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)

    Recruiting
    • Myelodysplastic Syndromes
    • Tamibarotene + Azacitidine
    • Tamibarotene Matched Placebo + Azacitidine
    • Tucson, Arizona
    • +87 more
    Feb 2, 2023

    Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

    Recruiting
    • Iron Deficiency Anemia
    • Adelaide, South Australia, Australia
    • +8 more
    Jun 23, 2023

    Myelodysplastic Syndrome Trial in Nagoya, Fukuoka, Tokyo (SyB L-1101)

    Completed
    Has Results
    • Myelodysplastic Syndrome
    • SyB L-1101
    • Nagoya, Aichi, Japan
    • +2 more
    Nov 14, 2022

    Myelodysplastic Syndrome Trial in Japan (SyB C-1101 and Azacytidine)

    Withdrawn
    • Myelodysplastic Syndrome
    • SyB C-1101 and Azacytidine
    • Nagoya, Aichi, Japan
    • +3 more
    Nov 14, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 27, 2023

    Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

    Completed
    • Myelodysplastic/Myeloproliferative Neoplasm
    • +2 more
    • Decidual stromal cells (DSC)
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

    Terminated
    Has Results
    • Acute Biphenotypic Leukemia
    • +29 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 4, 2023

    Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • VEN+AZA+Modified BUCY
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 10, 2023

    Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome Trial in Houston (BL-8040, horse anti-thymocyte globulin (hATG),

    Completed
    • Aplastic Anemia
    • Hypoplastic Myelodysplastic Syndrome
    • Houston, Texas
      MD Anderson Cancer Center
    Dec 28, 2020

    MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

    Recruiting
    • Myelodysplastic Syndromes
    • Chronic Myelomonocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital, Chinese Acade
    Jul 30, 2023

    MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

    Recruiting
    • Myelodysplastic Syndromes, de Novo
    • +10 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 23, 2023